tiprankstipranks
Trending News
More News >
LENZ Therapeutics (LENZ)
NASDAQ:LENZ
US Market

LENZ Therapeutics (LENZ) Income Statement

Compare
320 Followers

LENZ Therapeutics Income Statement

Last quarter (Q3 2025), LENZ Therapeutics's total revenue was $12.50M, an increase of Infinity% from the same quarter last year. In Q3, LENZ Therapeutics's net income was $-16.70M. See LENZ Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 15.00M$ 0.00$ 0.00
Gross Profit
$ -58.00K$ 0.00$ 15.00M$ -734.00K$ -121.00K
Operating Expenses
$ 58.55M$ 72.43M$ 25.48M$ 59.71M$ 13.38M
Depreciation and Amortization
$ 58.00K$ 15.00K$ 8.00K$ 734.00K$ 121.00K
EBITDA
$ -49.71M$ -72.41M$ -10.47M$ -70.03M$ -68.21M
Operating Income
$ -58.61M$ -72.43M$ -10.48M$ -60.44M$ -13.50M
Other Income/Expenses
$ 8.84M$ 2.28M$ 19.00K$ -10.32M$ -54.87M
Pretax Income
$ -49.77M$ -70.15M$ -10.46M$ -70.76M$ -68.37M
Net Income
$ -49.77M$ -69.97M$ -10.81M$ -70.76M$ -68.37M
Per Share Metrics
Basic EPS
$ -2.34$ -15.30$ -12.89$ -8.54$ -8.24
Diluted EPS
$ -2.34$ -15.30$ -12.89$ -8.54$ -8.24
Weighted Average Shares Outstanding
21.28M 8.15M 7.84M 8.29M 8.30M
Weighted Average Shares Outstanding (Diluted)
21.28M 8.15M 7.84M 8.29M 8.30M
Currency in USD

LENZ Therapeutics Earnings and Revenue History